Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Change in Acquisitions & Divestments (2022 - 2023)

Spruce Biosciences (SPRB) has disclosed Change in Acquisitions & Divestments for 2 consecutive years, with $9.3 million as the latest value for Q4 2023.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 46.86% to $9.3 million in Q4 2023 year-over-year; TTM through Sep 2024 was $9.3 million, a 87.74% decrease, with the full-year FY2023 number at $67.7 million, up 11.84% from a year prior.
  • Change in Acquisitions & Divestments was $9.3 million for Q4 2023 at Spruce Biosciences, down from $14.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $35.5 million in Q2 2022 to a low of $3.5 million in Q1 2022.